Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1982 Sep;46(3):452–456. doi: 10.1038/bjc.1982.225

Tumour-induced changes in murine lymphocyte profiles.

A Matossian-Rogers, P Rogers
PMCID: PMC2011127  PMID: 6982059

Full text

PDF
452

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoki T., Johnson P. A. Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation. J Natl Cancer Inst. 1972 Jul;49(1):183–192. [PubMed] [Google Scholar]
  2. Apffel C. A., Arnason B. G., Twinam C. W., Harris C. A. Recovery with immunity after serial tapping of transplantable mouse ascites tumours. Br J Cancer. 1966 Mar;20(1):122–126. doi: 10.1038/bjc.1966.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berendt M. J., North R. J. T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor. J Exp Med. 1980 Jan 1;151(1):69–80. doi: 10.1084/jem.151.1.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bertschmann M., Schären B., Lüscher E. F. Correlation of in vivo and in vitro immune reactions against the intradermally developing P-815 mastocytoma in the syngeneic mouse. Immunobiology. 1980 Jan;156(4-5):382–399. doi: 10.1016/S0171-2985(80)80072-6. [DOI] [PubMed] [Google Scholar]
  5. Chassoux D., MacLennan I. C., Munro T. R. Competition for cytotoxic immune capacity against a 'syngeneic' mouse tumour distributed at two sites. Int J Cancer. 1977 Jun 15;19(6):796–802. doi: 10.1002/ijc.2910190609. [DOI] [PubMed] [Google Scholar]
  6. Eckhardt L. A., Herzenberg L. A. Monoclonal antibodies to ThB detect close linkage of Ly-6 and a gene regulating ThB expression. Immunogenetics. 1980;11(3):275–291. doi: 10.1007/BF01567794. [DOI] [PubMed] [Google Scholar]
  7. Gershon R. K., Mokyr M. B., Mitchell M. S. Activation of suppressor T cells by tumour cells and specific antibody. Nature. 1974 Aug 16;250(467):594–596. doi: 10.1038/250594a0. [DOI] [PubMed] [Google Scholar]
  8. Hellström K. E., Hellström I. Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv Immunol. 1974;18:209–277. doi: 10.1016/s0065-2776(08)60311-9. [DOI] [PubMed] [Google Scholar]
  9. Kemp A., Berke G., Crowell J., Amos B. Induction of cell-mediated immunity against leukemia EL4 in C57BL mice. J Natl Cancer Inst. 1973 Dec;51(6):1877–1882. doi: 10.1093/jnci/51.6.1877. [DOI] [PubMed] [Google Scholar]
  10. Kuperman O., Fortner G. W., Lucas Z. J. Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity. J Immunol. 1975 Nov;115(5):1282–1287. [PubMed] [Google Scholar]
  11. Ledbetter J. A., Herzenberg L. A. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev. 1979;47:63–90. doi: 10.1111/j.1600-065x.1979.tb00289.x. [DOI] [PubMed] [Google Scholar]
  12. Ledbetter J. A., Rouse R. V., Micklem H. S., Herzenberg L. A. T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. J Exp Med. 1980 Aug 1;152(2):280–295. doi: 10.1084/jem.152.2.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Oi V. T., Herzenberg L. A. Localization of murine Ig-1b and Ig-1a (IgG 2a) allotypic determinants detected with monoclonal antibodies. Mol Immunol. 1979 Dec;16(12):1005–1017. doi: 10.1016/0161-5890(79)90034-8. [DOI] [PubMed] [Google Scholar]
  14. Perry L. L., Benacerraf B., Greene M. I. Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivo. J Immunol. 1978 Dec;121(6):2144–2147. [PubMed] [Google Scholar]
  15. Sjögren H. O., Hellström I., Bansal S. C., Hellström K. E. Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes. Proc Natl Acad Sci U S A. 1971 Jun;68(6):1372–1375. doi: 10.1073/pnas.68.6.1372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Takei F., Levy J. G., Kilburn D. G. Characterization of suppressor cells in mice bearing syngeneic mastocytoma. J Immunol. 1977 Feb;118(2):412–417. [PubMed] [Google Scholar]
  17. Wagner H., Hardt C., Bartlett R., Röllinghoff M., Pfizenmaier K. Intrathymic differentiation of cytotoxic T lymphocyte (CTL) precursors. I. The CTL immunocompetence of peanut agglutinin-positive (cortical) and negative (medullary) Lyt 123 thymocytes. J Immunol. 1980 Dec;125(6):2532–2538. [PubMed] [Google Scholar]
  18. Whitney R. B., Levy J. G. Effects of sera from tumor-bearing mice on mitogen and allogeneic cell stimulation of normal lymphoid cells. J Natl Cancer Inst. 1975 Mar;54(3):733–741. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES